Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Oxford Parkinson's Disease Centre Logo: the OPDC is funded by Parkinson's UK. Change attitudes. Find a cure. Join us.

2024

January

"Gene therapy to study and treat Parkinson’s disease".

 

March 

"Dissecting Parkinson's disease with long-read RNA-sequencing".

2023

January

Dr. Daniela Berg, University Medical Center Schleswig-Holstein, Germany

"Prodromal PD-definition and impact for clinical studies".

 

February

Professor Malú Gámez Tansey, University of Florida, USA

"Inflammation and immune dysfunction in Parkinson’s disease: targeting the gut-brain axis to reduce risk and progression".

 

March

Professor Pascal KaeserHarvard Medical School, USA

"Mechanisms and Roles of Fast Dopamine Signaling".

 

April

Dr Ziv Gan-Or,  McGill University, USA

"Genetics of synucleinopathies and how it informs us towards future clinical trials".

 

May

Professor Patrik Verstreken,  Leuven Brain Institute, Belgium

"The cellular phase of Parkinson’s disease".

 

June

Dr Ted. M. Dawson, Johns Hopkins University School of Medicine, USA

"Beyond Alpha-Synuclein: Exploring the Diversity of Molecular Mechanisms Underlying Parkinson's Disease".

 

July

Dr Ole Tietz, Dementia Research Centre, Macquarie University, NSW, Australia

"Towards Intraneuronal Immunotherapy"

Professor Rejko Krüger, Luxembourg Institute of Health

"New stratification concepts for precision medicine in the diagnosis and treatment of Parkinson’s disease".

 

October

Dr Alexandra Nelson, Neurology University of California, San Francisco

"Striatal Circuitry in Parkinson's Disease and Levodopa-Induced Dyskinesia

 

November

Dr Patrick Lewis, Royal Veterinary College, London

"Exploring the crosstalk between familial and idiopathic Parkinson’s"

 Professor Christos Proukakis, University College London

" Somatic mutations in the brain: do they have a role in synucleinopathies?"

 

December

Professor Poul Henning Jensen, Aarhus University, Denmark

"Rethinking Parkinson’s disease pathophysiology & how to model it with a focus on alpha-synuclein & cell autonomous processes"

2022

January

Professor Pietro De CamilliYale University School of Medicine, Kavli Institute for Neuroscience New Haven, USA

"Intracellular Membrane Lipid Dynamics and Neurodegenerative Diseases".

 

February

Professor Louis-Eric Trudeau, Faculty of Medicine Université de Montréal

"Making sense of the exuberant axonal connectivity of dopamine neurones".

 

May

Dr Nicole Calakos, Dept. of Neurology, Duke University, School of Medicine, USA

"A hidden regulator of neuromodulation and motor learning: Protein synthesis by the integrated stress response (ISR)".

Dr Kevin McFarthing, Research Advisor, Parkinson’s UK Oxford Branch

"The drug development landscape in Parkinson's".

 

June

Dr. Mark R. Cookson, Laboratory of Neurogenetics, National Institute on Aging (NIA), USA

"The role of LRRK2 in familial and sporadic Parkinson’s disease".

 

July

Dr Clemens Scherzer, Harvard Medical School, USA

"Cell circuits, progression genetics, and the quest to solve Parkinson’s with precision medicine".

 

October

Suzanne Pfeffer, Ph.D, Stanford University School of Medicine, USA

"LRRK2 kinase in Parkinson’s disease: from single molecule to the brain".

2021

January

Dr Wilma van de Berg, Amsterdam UMC

"Tales from the human brain: a multi-scale approach to elucidate pathogenic mechanisms involved in Parkinson’s"

 

February

Dr Emmanouil Metzakopian, UK Dementia Research Institute (UK DRI), University of Cambridge

"CRISPR-Cas9 genetic screens to ameliorate cellular stress in neurodegeneration"

 

March

Dr Nicolas Tritsch, Neuroscience Institute and Marlene & Paulo Fresco Institute for Parkinson’s & Movement Disorders, New York University

"Modulation of striatal circuits by midbrain dopamine neurons"

 

April

Dr Anne Grünewald, University of Luxembourg

“Mitochondrial DNA at the interface between mitochondrial dysfunction and inflammation in Parkinson’s disease”.

 

May

Dr Per Borghammer, Aarhus University, Denmark

"Body-first & Brain-first Parkinson's disease - explaining motor asymmetry, non-motor subtypes, and dementia".

 

June

Dr Olga Corti, Institut du Cerveau – Paris Brain Institute

“Mitophagy dysfunction in autosomal recessive Parkinson’s disease: is it the whole story?"

 

July

Dr Mark HoweBoston University

“Sub-second Striatum Neuromodulatory Signaling on Multiple Spatial Scales During Learning and Action”.

 

September

Professor David Rubinsztein, University of Cambridge

“Autophagy and neurodegeneration".

 

October

Dr Sreeganga Chandra, Yale School of Medicine

“Synaptic Vesicle Endocytosis and Parkinson’s disease”.

 

November

Dr Michael HendersonVan Andel Institute

“Modulators of pathology progression in neurodegenerative disease”.

 

December

Professor Konstantinos MeletisDept. of Neuroscience, Karolinska Institutet, Stockholm, Sweden

“Molecular and functional organization of the mouse striatum".

2020

Download 2020 Seminar Series Brochure

 

January

Matthew LaVoie, Brigham and Women's Hospital & Harvard Medical School

"Proteostasis and Mitochondrial Pathways in the Pathogenesis and Treatment of Parkinson’s Disease"

 

February

Michael Ward, National Institute of Neurological Disorders and Stroke (NINDS)

"Combining iPSCs and ‘omics to identify molecular convergence in neurodegenerative disorders"

 

March

Hélène Plun-Favreau, UCL Institute of Neurology

"Mitophagy: from genetics to biology, and back" 

 

April

Daniel Otzen, Interdisciplinary Nanoscience Center (iNANO), Aarhus University

"Targeting cytotoxic alpha-synuclein oligomers in Parkinson’s Disease"

 

May

Vincenzo Bonifati, Erasmus University Medical Center, Rotterdam

"An update on the quest for genetic determinants in Parkinson’s Disease & related diseases"

 

June

Tim Bartels, UK Dementia Research Institute (DRI), University College London (UCL)

"Selective brain region vulnerability in Parkinson’s Disease is governed by α-Synuclein conformations"

 

July

Madeline Lancaster, MRC, Laboratory of Molecular Biology, Cambridge

"Exploring human brain structure and function using cerebral organoids"

 

September

Jacqueline Burré, Brain and Mind Research Institute at Weill Cornell Medicine, USA

"Function and Dysfunction of Synucleins – Membranes Matter"

 

October

D. James Surmeier, Feinberg School of Medicine at Northwestern University, USA

"Time to revise the classical model of basal ganglia dysfunction in PD: New insights from a novel, progressive mouse of mitochondrial complex I dysfunction"

 

November

Valina Dawson, John Hopkins University School of Medicine, Baltimore, Maryland, USA

"Decoding Parkinson’s Disease: New Therapeutic Opportunities"

 

December

Richard Youle, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, Maryland, USA

"Mechanisms of Innate Immunity and Parkinson’s Disease"

 

Back to top

2019

Download 2019 Seminar Series Brochure

 

February

Elisa Greggio, Department of Biology, University of Padova

"Molecular pathways to Parkinson's disease: more than neurons?"

 

March

Kirsten Harvey

UCL School of Pharmacy, "LRRK2 Mediated Cellular Function from Vesicular Trafficking to Gene Expression"

 

April

Darren Moore, Center for Neurodegenerative Science, Van Andel Research Institute

"Pathway to Parkinson’s Disease: A Tale of Two Genes"

 

May

Mart Saarma, University of Helsinki

"Unconventional Endoplasmic Reticulum Located Trophic Factor for Parkinson’s Disease"

 

June

Sonia Gandhi, UCL Queen Square Institute of Neurology

"The toxic consequences of protein aggregation in Parkinson's disease"

 

July

Austen Milnerwood, The Neuro, McGill University

"The Quest for Neuroprotection in Parkinson’s disease: reversing synaptic dysfunction"

Esther Sammler, University of Dundee

"Interrogating LRRK2 kinase pathway in human bio-samples in Parkinson’s disease"

 

September

Michael Coleman, Department of Clinical Neurosciences, University of Cambridge

"Mechanisms of axon degeneration in injury and disease"

 

October

Paolo Calabresi, University of Perugia, Italy

"Striatal synaptic dysfunction in Parkinson's disease"

Ellen Sidransky, National Human Genome Research Institute, NIH

"The magic in the web of it: How a rare disorder is helping to untangle the mysteries of Parkinson’s disease"

 

November

Evrando Fei Fang, University of Oslo

"NAD+ and Mitophagy in Brain Ageing and Neurodegenerative Disorders"

Jerome Baufreton, Laboratory of Synaptic and Cellular Dynamics of Neuronal Networks, The Neuroscience Institute at Bordeaux

"Synaptic alterations in the indirect-pathway of the basal ganglia in experimental Parkinsonism"

 

Back to top

2018

Download 2018 Seminar Series Brochure

 

January

Gary Miller, Rollins School of Public Health, Emory University

"Parkinson's disease: environmental clues and transporter blues"

 

Pierre-Herve Luppi, Centre de Recherche en Neurosciences de Lyon

"REM Sleep Behaviour Disorder: from circuits to pathology"

 

Emily Osterweil, Edinburgh University

"Cell type-specific translation profiling in fragile X"

 

February

Malú Tansey, Emory University School of Medicine

"Immune and inflammatory mechanisms underlying risk for age-related neurodegenerative disease"

 

March

Stéphane Palfi, Mondor Biomedical Research Institute

"Gene therapies for Parkinson's disease"

 

April

Andy West, University of Alabama at Birmingham

"Achieving Neuroprotection in Parkinson’s Disease"

 

May

Vladyslav Vyazovskiy, Department of Physiology, Anatomy and Genetics, University of Oxford

"Local and global facets of sleep regulation"

 

June

Hélène Plun-Favreau, UCL Institute of Neurology

"Mitophagy modulation as a potential therapeutic target for neurodegenerative diseases"

 

September

Barbara Picconi, Lab Neurofisiologia Sperimentale, Università Telematica San Raffaele

 

November

Mina Ryten, Institute of Neurology, University College London

 

December

Sonja Scholz, Neurodegenerative Diseases Research Unit, NIND, NIH

 

Back to top

2017

Download 2017 Seminar Series Brochure

 

January

Professor Olaf Horst, Rieß Institute of Medical Genetics and Applied Genomics, University of Tübingen

 

February

Dr Kostas Vekrellis, Biomedical Research Foundation Academy Of Athens

 

April

Professor Beate Ritz, School of Public Health at UCLA

 

May

Professor Hilal Lashuel, Brain Mind Institute. Swiss Federal Institute of Technology Lausanne

Professor Omar El-Agnaf, Qatar Biomedical Research Institute

 

June

Professor Steven Finkbeiner, Gladstone Institute of Neurological Disease/UCSF

 

July

Dr Michela Deleidi, Hertie Institute,University of Tübingen

 

August

Dr Kathleen Maguire-Zeiss, Georgetown University

 

September

Dr Mattia Volta, European Academy of Bolzano/Bozen (EURAC)

 

November

Dr Brit Mollenhauer, University Medical Center, Goettingen

 

December

Donato Di Monte, German Center for Neurodegenerative Diseases (DZNE)

 

Back to top

2016

Download 2016 Seminar Series Brochure

 

January

Professor Dario Alessi, MRC Protein Phosphorylation and Ubiquitylation Unit, University of Dundee

 

February

Professor Miquel Vila, Vall d’Hebron Research Institute (Barcelona)

 

March

Professor Malin Parmar, Developmental and Regenerative Neurobiology, Wallenberg Neuroscience Center, Lund University (Sweden)

 

April

Professor Robert Edwards, Department of Neurology, Graduate Program in Biomedical Sciences, University of California, (San Francisco)

 

May

Dr Valerio Zerbi, Department of Health Sciences and Technology ETH Zurich (Switzerland)

 

June

Professor Jia-Yi Li, Neural Plasticity and Repair group, Department of Experimental Medical Science, Lund University (Sweden)

 

July

Dr Mark Cooper, UK Parkinson’s Disease Consortium, UCL Institute of Neurology, University College London

 

September

Professor John Reynolds, Brain Research New Zealand/Dept of Anatomy, University of Otago Medical School

 

October

Dr Alastair Noyce, Institute of Neurology, University College London

 

November

Mickael Decressac, Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy

 

December

Professor Nick Allen, School of Biosciences, University of Cardiff

 

Back to top

2015

Download 2015 Seminar Series Brochure

 

January

Professor Rejko Krueger, University of Luxembourg

"Patient-based cellular models and stratified treatment options for Parkinson’s disease"

 

February

Professor Gilberto Fisone, Karolinska Institute

"Targeting abnormal signalling in experimental Parkinsonism and L-DOPA-induced dyskinesia"

Professor Alice Chen-Plotkin, University of Pennsylvania

"Unbiased Approaches to Parkinson's Disease Biomarker Discovery"

 

May

Professor Steven Gill, North Bristol NHS Trust, University of Bristol

"GDNF: Back to the Clinic"

 

November

Professor Giovanna Mallucci, University of Cambridge

"Neurodegeneration: molecules to medicines"

 

Back to top

2014

Download 2014 Seminar Series Brochure

 

January

Dr Max Little, Aston University

"Detecting Parkinson’s by voice analysis"

 

March

Professor Anthony Schapira, Institute of Neurology, University College London

"Glucocerebrosidase in Parkinson disease: insights into aetiology and potential therapies"

 

June

Dr Sabine Hilfiker, Institute of Parasitology and biomedicine

"Unravelling the pathogenic roles of LRRK2 in Parkinson’s disease"

 

July

Professor Thomas Gasser, University of Tübingen

"Genetic architecture of Parkinson’s disease"

 

September

Dr Patrick Lewis, Reading University

"Understanding LRRK2 – from cellular function to human disease"

 

October

Professor Ralph Nixon, New York University School of Medicine/Nathan Kline Institute

"Lysosomes: the Achille's heel of neurons in neurodegenerative disease"

 

November

Professor Paola Piccini, Imperial College London

"Pre- and post-synaptic mechanisms in L-dopa-induced dyskinesia: evidence from functional imaging"

 

December

Professor Matt Farrer, University of British Columbia

"Parkinsonism: etiology, pathogenesis and pathology from a genetic perspective"

 

Back to top

2013

Download 2013 Seminar Series Brochure

 

January

Professor David Brooks, Department of Medicine, Imperial College London

"Functional Imaging in Parkinson’s Disease"

 

February

Professor Nicholas Wood, Institute of Neurology, University College London

"Genetics of Parkinson’s disease: implications for functional follow up"

 

March

Dr Edward Fon, Montreal Neurological Institute, McGill University

"Function of Parkinson's Disease Genes in Mitochondrial Quality Control"

Professor Christine Klein, Department of Neurology, University of Luebeck

"Modeling genetic and idiopathic Parkinson's disease with induced pluripotent stem (iPS) cell-derived neurons"

 

April

Dr Erwan Bezard, Institut des Maladies Neurodégénératives, Université Victor Segalen Bordeaux 2

"Peculiar behavior of D1 dopamine receptor in 1-dopa induced dyskinesia"

 

May

Dr Nin Bajaj, National Parkinson Foundation Centre of Excellence in Parkinson’s Disease, University of Nottingham

"3T and 7T MRI studies in Parkinson’s disease: some recent advances"

 

June

Professor David Sulzer, Departments of Neurology and Psychiatry, Columbia University Medical Centre

"The dopamine synapse in normal function and disease"

 

July

Dr Antonio Pisani, Department of Neuroscience, University of Rome Tor Vergata

"Relevance of the striatal cholinergic system in basal ganglia function and dysfunction"

 

October

Dr Kelvin Luk, Center for Neurodegenerative Disease Research, University of Pennsylvania

"Propagation of misfolded alpha-synuclein: implications for Parkinson’s disease"

 

November

Dr Manju Kurian, Institute of Child Health, University College London

"Dopamine Dyshomeostasis in Childhood Neurological Syndromes"

 

December

Professor Ole Isacson, Harvard Medical School, Center for Neuroregeneration Research, McLean Hospital

"Rethinking Parkinson’s disease science and regenerative treatments"

 

Back to top

2012

Download 2012 Seminar Series Brochure

 

January

Professor Tamas Revesz, University College London

"Progression of neuropathology in Parkinson’s Disease"

 

February

Dr Oliver Bandmann, Sheffield Institute of Translational Neuroscience, University of Sheffield

"New strategies to identify disease – modifying treatment for Parkinson’s Disease"

 

March

Dr Huaibin Cai, National Institute on Ageing, NIH, USA

"Molecular determinants of dopaminergic neuron loss in Parkinson’s Disease"

 

April

Dr Kostas Vekrellis, Biomedical Research Foundation, Athens, Greece

"In vivo assessment of alpha-synuclein secretion. Possible therapeutic implications in Parkinson’s Disease"

 

May

Dr Clive Svendsen, Cedars-Sinai Regenerative Medicine Institute, Los Angeles, USA

'“Disease in a dish”: A new era for modelling human neurological disorders with stem cells'

 

June

Professor Birgit Liss, Institute of Applied Physiology, University of Ulm, Germany

"Distinct functions and fates of dopamine midbrain neurons in health and Parkinson's Disease - a tale of two ion channels?"

 

July

Dr Tiago Outeiro, Cell and Molecular Neuroscience Unit, Faculdade de Medicina de Lisboa, Portugal

"From the baker to the bedside: unraveling the molecular basis of Parkinson’s Disease"

 

September

Professor Kevin Morgan, Faculty of Medicine & Health Sciences, University of Nottingham

"Biomarker discovery in Alzheimer's disease-myth or reality?"

 

October

Professor Uwe Walter, Department of Neurology, University of Rostock

"Value of transcranial sonography in the diagnosis and treatment of Parkinson's disease"

Dr Tilo Kunath, Centre for Regenerative Medicine, University of Edinburgh

"Modelling synucleinopathies with human pluripotent stem cells"

 

November

Professor Masud Husain, Nuffield Department of Clinical Neurology and Department of Experimental Psychology, University of Oxford

"Inattention, Impulsivity and Apathy in Parkinson's disease"

 

December

Dr Nick Allen, School of Biosciences, Cardiff University

"Stem cell-derived neuronal models to study Huntington's disease"

Professor Ola Söderberg, Department of Immunology, Genetics and Pathology, Uppsala University

"Analysis of signaling network activity at a single cell level"

 

Back to top

2011

Download 2011 Seminar Series Brochure

 

January

Professor Tipu Aziz, Oxford Functional Neurosurgery, University of Oxford

"Pedunculopontine nucleus stimulation for the treatment of drug resistant freezing and falls in Parkinson’s Disease"

 

February

Dr Maeve Caldwell, School of Clinical Sciences, University of Bristol

"Stem cell therapy for Parkinson’s Disease, lessons from the developing brain"

 

March

Professor Paul Matthews, GSK Clinical Imaging Centre, Imperial College, London

"The Challenge of Imaging Neurodegeneration in Parkinson’s Disease"

Professor Howard Federoff, Georgetown University Medical Center

"Systems Neuromedicine & Parkinson’s Disease"

 

May

Professor Margaret Rice, Department of Neurosurgery, New York University School of Medicine

"How H2O 2 mediates and modulates neurotransmission in the basal ganglia"

 

June

Alex Green, Oxford Functional Neurosurgery

"Pendunculopontine nucleus stimulation for the treatment of drug resistant freezing and falls in Parkinson’s Disease"

 

July

Professor Yoav Ben-Shlomo, Department of Social Medicine, University of Bristol

"Epidemiological insights into the understanding of Parkinson’s Disease"

 

September

Professor Alfred Goldberg, Department of Cell Biology, Harvard University

"Functions of the Proteasome: from clearing misfolded proteins to cancer therapy"

 

October

Dr Vania Broccoli, Stem Cells and Neurogenesis Unit, San Raffaele Scientific Institute, Milan

"Generating iDA neuronal cells by direct reprogramming of mouse and human fibroblasts without pluripotent cell intermediates"

 

November

Dr Roger Barker, Department of Clinical Neurosciences, University of Cambridge

"The Hetrogeneity of Parkinson’s Disease – its basis and therapeutic implications"

Professor John Hardy, Department of Neurology, Reta Lila Weston Institute of Neurological Studies

"Genetic anaylsis of neurodegeneration"

 

Back to top

2010

Download 2010 Seminar Series Brochure

 

May

Professor Patrik Brundin, Lund University, Sweden

 

June

Professor Julie Williams, Department of Psychological Medicine and Neurology, Cardiff University School of Medicine

"Defining the Genetic Architecture of Alzheimer's Disease"

 

July

Dr Huw Morris, Department of Psychological Medicine and Neurology, Cardiff University School of Medicine

"Clinical and Genetic Analysis of Early Onset Parkinson's Disease"

 

September

Dr Andrew Singleton, National Institute on Aging, NIH, USA

"Identifying and Understanding the Genetic Basis of Parkinson’s Disease"

 

October

Professor Steve Dunnett, Cardiff School of Biosciences, Cardiff University Functional Mechanisms of Repair and Recovery by Ventral Mesencephalic Tansplants in the Striatum

 

November

Professor Robin Franklin, Cambridge Centre for Brain Repair, University of Cambridge CNS remyelination: from biology to therapy

 

December

Professor David Burn, Clinical Ageing Research Unit, Newcastle University Dementia in Parkinson’s Disease: What’s new?

 

Back to top

On this page